Enjoy complimentary customisation on priority with our Enterprise License!
Based on the hypercalcemia treatment market analysis, the global hypercalcemia treatment market is expected to grow at a steady rate and post a CAGR of more than 5% during the forecast period. The increasing instances of surgical procedures, such as hip and knee replacements, will increase the risk of hypercalcemia and drive the growth prospects for the global hypercalcemia treatment market in the upcoming years. The study also shows that the prevalence of broken bone repair surgeries, cardiovascular procedures, percutaneous coronary interventions, joint replacement surgeries, knee replacement surgeries, hip replacement surgeries, and cases of coronary artery bypass grafting will increase the chances of developing hypercalcemia post surgeries. Consequently, the demand for hypercalcemia treatment drugs will also increase during the predicted period.
The growing preference for combination therapy will drive the prospects for the global hypercalcemia treatment market growth until the end of 2021. The adoption rate and preference for hypercalcemia drugs is increasing in developed countries with the growing use of hypercalcemia drugs in combination with other therapies. For instance, researchers have evaluated the use of combination drugs, which includes pamidronate and calcitonin. Additionally, it has also been observed that the reduction in elevated serum parathyroid hormone (PTH) levels and the improvement of bone mineral density can be achieved using denosumab (DMAb) and calcitriol. Such combination therapies will lead to a new therapeutic strategy to reverse severe bone loss due to therapy-resistant SHPT in individuals with CKD.
The global hypercalcemia treatment market is fragmented and is characterized by the presence of various local, regional, and international vendors. The growing rate of endocrine disorders such as hyperparathyroidism and kidney diseases will propel the demand for the production of drugs. The vendors in the market are increasingly competing against each other based on factors such as aggressive pricing and new indications. To penetrate further into the hyperparathyroidism market, several vendors are focusing on conducting extensive research and developmental activities and gain approvals. Furthermore, a large number of market players are also increasingly developing effective treatments for spasticity due to the high unmet medical needs.
Key vendors in this market are -
Other prominent vendors in the market include DiaSorin, Rockwell Medical, Kyowa Hakko Kirin, and Fujirebio.
The bisphosphonates segment dominated the global hypercalcemia treatment market during 2016 and is likely to experience a high growth rate during the estimated period. The dominant position of this segment is mainly due to the growing demand for preventive treatment of hypercalcemia, the availability of a wide range of bisphosphonates, established clinical evidence, and the increasing number of disorders such as resistant hypercalcemia or heterotopic calcification.
The Americas was the largest revenue contributor that accounted for a significant portion of the market shares during 2016 and is estimated to dominate the market in the forthcoming years as well. Factors such as the growing incidence of hyperparathyroidism and kidney disease, expanding label indications, the increasing competition from generic players, and the growing focus of vendors in developing novel drugs, will drive the market’s growth in this region.
Technavio also offers customization on reports based on specific client requirement.
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: An overview of Hypercalcemia
PART 06: Pipeline Analysis
PART 07: Market landscape
PART 08: Market segmentation by product type
PART 09: Market segmentation by geography
PART 10: Decision framework
PART 11: Drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
PART 14: Key vendor analysis
PART 15: Appendix
Tags: long term care, cardiovascular procedures, electrical appliances, lab equipment, hypercalcemia treatment market size, health and wellness market share,
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.